Raffles Medical posts 63.8% drop in H2 profit to S$30.3 million; looks to China, Japan growth
RAFFLES Medical Group posted a 63.8 per cent drop in net profit to S$30.3 million for the second half ended Dec 31, 2023, from S$83.7 million in the previous corresponding period.
The group attributed the weaker performance to the discontinuation of Covid-19-related activities in FY2023, it said on Monday (Feb 26).
The results translate to earnings per share (EPS) of 1.63 Singapore cents against EPS of 4.51 cents previously.
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Copyright SPH Media. All rights reserved.